Share The best way to keep up to date with all of the latest, cutting edge technologies from the lab to the market! Visit Blog JOIN SCI FOR UNLIMITED ACCESS TO C&I Nanocomposites update Michael Gross ...
Trends in most industries tend to be cyclical and the pharmaceutical contract manufacturing industry is no exception. Looking back at contract manufacturing organisations (CMOs) over the last forty years, a number of defined stages and trends have become apparent in their evolution.
The exterior cladding of the Grenfell Tower in West London has come in for much criticism following the blaze in June, which left 80 people dead. Since the fire, the UK Building Research Establishment (BRE) has been testing the combustibility of cladding material from buildings around the country. As of 3 July, all 181 samples had failed.
Declining paper sales have spurred mill owners to diversify their operations into other potentially more lucrative areas - including biomaterials, Cath O’Driscoll reports
The pharma industry is struggling to maintain its position in the face of major challenges (innovation, quality and regulations…) that threaten its ability to deliver new drugs.
A fifth of male fish in English rivers now have both female and male or intersex characteristics, according to Exeter University research, which blames hormone-disrupting chemicals that are flushed away and enter wastewater effluents that pass into rivers and streams.
The global pharmaceutical industry is at a critical point, as Magid Abou-Gharbia, director of Temple University's Moulder Center for Drug Discovery Research, told delegates at CPhI/Informex, held in Philadelphia, US, in April 2017.
Australian researchers have overcome a critical hurdle in boosting plant performance by manipulating gene networks. They ‘trick’ plants into thinking phosphate is scarce, which leads them to use this essential nutrient up to 50% more efficiently
Nine start-ups and one university research department begin a joint venture with AkzoNobel to submit solutions to challenges linked to the company’s portfolio.
David Cameron sought to reassure biotech companies represented at the 2017 BIO Convention in San Diego about the business environment in the UK following Brexit.